Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already ...
Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...
I’m 63 and have been diagnosed with atrial fibrillation. I wonder what you know about medical care and self-care for the ...
The FDA resolved the shortage of Eli Lilly's tirzepatide, but may revisit allowing compounding pharmacies to make copies, ...
A peculiar case of a woman who took tapeworm egg pills as a quick-fix solution to lose weight has come to light. Doctors said ...
News Obese Children Are More Likely to Develop Skin Conditions Related to the Immune System. Childhood obesity can contribute to the development of common immune-mediated skin dis ...
Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of ...
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
She would have periods in time where she’d suddenly wake up in the middle of the day and she couldn’t remember anything from ...
The future of the weight loss market might not revolve around GLP-1 drugs.
A dietitian shares the science-backed weight loss supplements that support weight loss when paired with a balanced diet and active lifestyle.
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...